ABx Group (ASX: $ABX) achieves higher fluorine recovery in bath pilot batch reactor tests

ABx Group (ASX: $ABX) has announced that independent assessments of powder samples from further runs of its 83%-owned subsidiary ALCORE's bath pilot batch reactor have indicated higher fluorine recovery. The latest test runs have achieved 80% fluorine recovery in a single stage, with plans for further processing to achieve 88% recovery. The next stage of work is planned to involve a combination of the bath pilot batch reactor and a specialised laboratory reactor.

Executive Commentary on Bath Pilot Batch Reactor Tests

ABx Group Managing Director and CEO Dr Mark Cooksey expressed his satisfaction with the progress, stating, 'I am pleased with our progress and with the ongoing increase in fluorine recovery with each reactor test ALCORE has undertaken. As anticipated, the newly commissioned equipment which allowed bath feed particle size to be optimized has assisted in achieving a higher recovery of fluorine in the latest test runs. The next stage of development work is planned to involve using the existing specialised laboratory reactor to serve as the second process stage. It is anticipated that the combination of the bath pilot batch reactor and the specialised laboratory reactor can produce a higher fluorine recovery. We are in the process of planning further reactor tests over the coming months and look forward to keeping investors up-to-date about these future results.'

Summary of Bath Pilot Batch Reactor Update

ABx Group (ASX: $ABX) has reported higher fluorine recovery in the latest test runs of ALCORE's bath pilot batch reactor. The achievement of 80% fluorine recovery in a single stage is a significant development, with plans for further processing to achieve 88% recovery. The company is optimistic about the potential of a second stage process using a different reactor configuration to further increase the fluorine recovery to over 90%. The next stage of work will involve using a specialised laboratory reactor to serve as the second process stage, aiming to produce a higher fluorine recovery. ABx Group is planning further reactor tests over the coming months and is committed to keeping investors informed about the future results.